Skip to content

Effectiveness of Standard Urotherapy in children and adolescents with DUI: A Randomized Controlled Trial (RCT).

Effectiveness of Standard Urotherapy in children and adolescents with DUI: A Randomized Controlled Trial (RCT).

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON20684
Enrollment
71
Registered
2020-10-16
Start date
2023-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Day-time urinary incontinence (DUI) and non-retentive faecal incontinence (NFI)

Interventions

Sponsors

SeysCentra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All participants meet the following inclusionary criteria: They (a) have DUI, assessment and diagnosis using ICCS criteria (von Gontard, 2013b; Austin et al., 2016), and/or (b) have NFI, assessment and diagnosis using Rome IV criteria (von Gontard, 2013a; Hyams et al., 2016), (c) underwent a paediatric examination (d) have an IQ =35, (e) have ability to stand and walk, have (f) no visual impairment, (g) have the ability to imitate, (h) SU training hasn't been previously contucted, and (i) participated in study 1, 2, or 3.

Exclusion criteria

Exclusion criteria: Participants will be excluded from this research study based on the following exclusion criteria: They (a) have an IQ = 34, (b) are unable to stand or walk, (c) have a visual impairment, (d) are unable to imitate based on video modelling imitation probes, (e) do not have NFI or DUI or (f) received a completed SU training according to the ICCS criteria (von Gontard, 2013b) at a different facility, or (g) completed an SU training which was effective in attaining continence.

Design outcomes

Primary

MeasureTime frame
self-initiated toileting and urinary/faecal accidents during treatment/post-intervention

Secondary

MeasureTime frame
self-initiated toileting and urinary/faecal accidents during follow-up.

Contacts

Public ContactMaayke van Galen

Radboud Universiteit/SeysCentra

mgalen02@seyscentra.nl0634030491

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jul 3, 2026